Австралия - английски - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - leflunomide, quantity: 10 mg - tablet, uncoated - excipient ingredients: lactose; crospovidone; colloidal anhydrous silica; magnesium stearate - leflunomide apotex is indicated for the treatment of: active rheumatoid arthritis; active psoriatic arthritis. genrx leflunomide is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. the combined use of genrx leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).

Австралия - английски - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - leflunomide, quantity: 20 mg - tablet, uncoated - excipient ingredients: crospovidone; magnesium stearate; colloidal anhydrous silica; lactose - leflunomide apotex is indicated for the treatment of: active rheumatoid arthritis; active psoriatic arthritis. genrx leflunomide is not indicated for the treatment of psoriasis that is not associated with manifestations of arthritic disease. the combined use of genrx leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).

Австралия - английски - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - leflunomide -

Канада - английски - Health Canada

odan laboratories ltd - leflunomide - tablet - 10mg - leflunomide 10mg - disease-modifying antirheumatic agents

САЩ - английски - NLM (National Library of Medicine)

avera mckennan hospital - leflunomide (unii: g162gk9u4w) (leflunomide - unii:g162gk9u4w) - leflunomide 20 mg

Канада - английски - Health Canada

sandoz canada incorporated - leflunomide - tablet - 10mg - leflunomide 10mg - disease-modifying antirheumatic agents

Канада - английски - Health Canada

accel pharma inc - leflunomide - tablet - 10mg - leflunomide 10mg - disease-modifying antirheumatic agents

Австралия - английски - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - leflunomide, quantity: 10 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; povidone; crospovidone; magnesium stearate; lactose monohydrate; maize starch; titanium dioxide; hypromellose; macrogol 4000 - treatment of active rheumatoid arthritis. the combined use of leflunomide with other disease modifying antirheumatic drugs (dmards) has not been adequately studied (see precautions).

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution - leflunomide - tablet - 10mg

Великобритания - английски - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - leflunomide - tablet - 10mg